Literature DB >> 30878674

HLA-C*01:02 and HLA-A*02:07 Confer Risk Specific for Psoriatic Patients in Southern China.

Minglong Cai1, He Huang1, Delin Ran2, Xiaodong Zheng2, Leilei Wen2, Zhengwei Zhu2, Lu Liu2, Chuanliang Zhang2, Xiaojie Hong2, Jiaqi Hong2, Wenjuan Wu2, Jie Ma2, Mingshun Wu2, Danfeng Qian2, Yujun Sheng3, Xuejun Zhang4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30878674     DOI： 10.1016/j.jid.2019.02.027

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  4 in total

1.  Associations between HLA-Cw1 and Systemic Treatment Response of Asian Psoriasis Patients.

Authors:  Shin-Shin Ho; Tsen-Fang Tsai
Journal:  Mol Diagn Ther       Date:  2022-07-05       Impact factor: 4.476

2.  Psoriasis Patients with Specific HLA-Cw Alleles and Lower Plasma IL-17 Level Show Improved Response to Topical Lindioil Treatment.

Authors:  Chuang-Wei Wang; Rosaline Chung-Yee Hui; Wen-Hung Chung; Yin-Ku Lin; Ching-Ya Wang; Yu-Huei Huang; Ya-Ching Chang; Chun-Bing Chen
Journal:  Pharmgenomics Pers Med       Date:  2022-05-13

3.  A Large-Scale, Stratified Genetic Analysis of the Major Histocompatibility Complex Region in Early- and Late-Onset Psoriasis in China.

Authors:  Yi Zhou; Minglong Cai; Yujun Sheng; Xuejun Zhang
Journal:  Ann Dermatol       Date:  2020-12-30       Impact factor: 1.444

Review 4.  HLA-Cw1 and Psoriasis.

Authors:  Yi-Wei Huang; Tsen-Fang Tsai
Journal:  Am J Clin Dermatol       Date:  2021-01-18       Impact factor: 7.403
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.